Antineutrophil cytoplasmic antibodies in chronic idiopathic intraocular inflammatory disease

Ocular Immunology and Inflammation

Volumn 4, Issue 2, 1996, Pages 83-90

  Chan, T K J ^a   Dick, A D ^a   Forrester, J V ^a,c   Herriot, R ^b  

^a Department of Ophthalmology ^*  (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

ANCA; Endogenous posterior uveitis; Immunosuppression; Intraocular inflammation

Indexed keywords

GRANULOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; EYE INFLAMMATION; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; TOPICAL DRUG ADMINISTRATION;

EID: 0030014234     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.3109/09273949609079637     Document Type: Article

References (41)

1. Forrester JV. Endogenous posterior uveitis. Br J Ophthalmol 1990; 74:620-623.
2. Forrester JV. Uveitis pathogenesis. Lancet 1991; 338:1498-1501.
3. Dick AD, Cheng YF, Purdie AT, Liversidge J, Forrester JV. Immunocytochemical analysis of blood lymphocytes in uveitis. Eye 1992; 6:643-647.
4. Feron E, Calder V, Lightman S. Distribution of IL-2R and CD45 RO expression on CD4+ and CD8+T-lymphocytes in posterior uveitis using 3-colour flow cytometric analysis. Curr Eye Res 1992; 11:167-172.
5. Deschennes J, Char DH, Kalita S. Activated T-lymphocytes in uveitis. Br J Ophthalmol 1986; 72:83-87.
6. Arocker-Mettinger E, Steurer-Georgiew L, Steure M, Huber-Spitzy V, Hoelzl E, Grabner G, Kuchar A. Circulating ICAM-I levels in serum of uveitis patients. Curr Eye Res 1992; 11:161-166.
7. Edelsten C, D'Cruz D, Hughes GRV, Graham EM. Antiendothelial cell antibodies in retinal vasculitis. Curr Eye Res 1992; 11:203-208.
8. Klok AM, Geertzen R, Rothova A, Seerp Baarsma G, Kijlstra A. Anticardiolipin antibodies in uveitis. Curr Eye Res 1992, 11:209-213.
9. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983; 96(3):275-282.
10. Towler HMA, Lightman SL, Forrester JV. Low dose cyclosporin therapy of ocular inflammation: preliminary report of a long term follow up study. J Autoimmunity 1992; 5(suppl A):259-264.
11. Towler H, Cliffe A, Whiting P, Forrester JV. Low dose cyclosporin A therapy in chronic posterior uveitis. Eye 1989; 3:282-287.
12. Towler HM, Whiting PH, Forrester JV. Combination of low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye 1990; 4:514-520.
13. Dick AD, Towler HMA, Whiting P, Forrester JV. The use of lithium clearance studies in the early detection of cyclosporin nephrotoxicity: a protocol of renal function assessment with cyclosporin therapy. Curr Eye Res. 1992; 11:215-218.
14. Lightman S. Uveitis management. Lancet 1991; 338:1501-1504.
15. Harrison DJ, Simpson R, Kharbanda R, Abernethy VE, Nimmo G. Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax 1989; 44:373-377.
16. DeKeizer RJW, van der Woude FJ. c-ANCA test and the detection of Wegener's disease in sclerokeratitis and uveitis. Curr Eye Res 1990; 9(suppl.):59-61.
17. Van der Woude FJ, Lobatto S, Permin H, van der Giessen M, Rasmussen N, Wiik A, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425-429.
18. Soukiasian SH, Foster SC, Niles JL, Raizman MB. Diagnostic value of ANCA in scleritis associated with Wegener's granulomatosis. Ophthalmology 1992; 99:125-132.
19. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CGM. Prevention of relapses in Wegener's granulomatosis by treatment based on ANCA titre. Lancet 1990; 336:709-711.
20. Specks U, DeRemee RA. Significance of antibodies to cytoplasmic components of neutrophils. Thorax 1989; 44:369-370.
21. Pulido JS, Goeken JA, Nerad JA, Sobol WM, Folberg R. Ocular manifestation of patients with circulating ANCA. Arch Ophthalmol 1990; 108:845-850.
22. Jennette CJ. Antineutrophil cytoplasmic antibodies-associated diseases. A pathologist's perspective. Am J Kidney Dis 1991; 18:164-170.
23. Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337:1137-1139.
24. Jayne DRW, Jones SJ, Severn A, Shaunak S, Murphy J, Lockwood CM. Severe pulmonary haemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasmic antibodies of IgM class only. Clin Nephrol 1989; 32:101-106.
25. Young DW, Dring S, Thompson R. Anti-neutrophil cytoplasmic antibodies in uveitis. Curr Eye Res 1990; 9:41-44.
26. Young DW. The antineutrophil antibody in uveitis. Br J Ophthalmol 1991; 75:208-211.
27. Ayliffe W, Haeney M, Roberts SC, Lavin M. Uveitis after ANCA contamination of immunoglobulin replacement therapy. Lancet 1992; 339:558-559.
28. Hagen EC, van de Vijver-Reenalda H, de Keizer RJW, Kijlstra A, van Es LA, Daha MR, van der Woude FJ. Uveitis and ANCA. Clin Exp Immunol 1994; 95:56-59.
29. Jenne DE, Tschopp J, Ludermann J, Utecht B, Gross WL. Wegener's autoantigen decoded. Nature 1990; 346:520.
30. Lesavre P. Antineutrophil cytoplasmic antibodies antigen specificity. Am J Kidney Dis 1991; 18:159-163.
31. Jennette CJ, Falk RJ, Antineutrophil cytoplasmic antibodies and associated diseases: A review. Am J Kidney Dis 1990; 15:517-529.
32. Gross WL, Csernok E, Schmitt WH. ANCA: Immunological aspects. Klin Wschr 1991; 69:558-566.
33. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91:1-12.
34. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92:467-471.
35. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97(suppl.6):12-14.
36. Hagen CE, Ballieux BEPB, van Es LA, Daha MR, van der Woude FJ. ANCA: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 1993; 81:1996-2002.
37. Falk RJ, Terrell RS, Charles LA, Jennette CJ. ANCA induce neutrophils to degranulate and produce oxygen radical in vitro. Proc Natl Acad Sci USA 1990; 87:4115-4119.
38. Van der Woude FJ, Daha MR, van Es LA. The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol 1989; 78:143-148.
39. Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGKr, Weening JJ. Autoimmunity to lysosomal enzymes: new clue to vasculitis and glomerulonephritis? Immunol Today 1991; 12:61-64.
40. Ewert B, Jennette CJ, Falk R. ANCA stimulate cytokine-primed neutrophils to damage endothelial cells. J Am Soc Nephrol 1990; 1:520.
41. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992; 141:335-342.